Insulin capsules - a promising alternative to injections

Researchers from the Robert Gordon University in Aberdeen, UK, presented a study at The British Pharmaceutical Conference, held from 10th to 12th September, 2007, at Manchester Central, showing that a chemical coating is able to encapsulate and protect insulin against enzymes that usually break down the hormone in the gastrointestinal tract.

Photo: Insulin capsules - a promising alternative to injections

The special chemical coating, known as novel polymer and synthesised in laboratories, could protect orally taken insulin from enzyme breakdown. Unhindered, the insulin could enter the blood stream and take effect on blood glucose levels. Insulin is usually delivered to the body by the way of injection. In future, the chemical coating could allow insulin to be taken orally for treatment of type 1 and type 2 diabetes.

“We have been working on developing an oral insulin because studies show that a great many people with diabetes fear injections. Being able to take insulin orally would have a significant impact on the lives of many of the patients – not just eliminating the need for injections, but also offering a much more convenient form of treatment,” explains Dr Colin Thompson, Research Fellow, who works under the supervision of Dr Woei Ping Cheng at the university’s School of Pharmacy.

Many general practitioners delay the initiation of insulin treatment for type 2 diabetics as they assume that the patients would dislike or fear the injections.
Oral insuline as an alternative to injections - there are still numerous hurdles the researchers need to overcome. “Further testing of this complex is needed to determine its suitability as an insulin delivery system – a goal that is some years away. However, our research is taking us a significant step forward towards this important goal and offering hope to people who are living with diabetes,” concludes Dr Thompson.



More on the subject:
Read all latest stories

Related articles


News • Sustainability assessment

EU laws need to look at the environmental impact of pharmaceuticals, study finds

Current EU regulation does not adequately consider the environmental emissions of pharmaceuticals in global manufacturing supply chains, a recent study from Finland concludes.


News • A winning combination

‘Cocktail’ vaccines to offer protection against future Covid-19 variants

Covid-19 vaccinations that combine two or more distinct variants of SARS-CoV-2 could offer protection against current and future ‘variants of concern’, say scientists from UK and Austria.


News • Study on meth, cannabis, cocaine and opiate use

Illicit drugs linked with atrial fibrillation

Methamphetamines, cocaine, opiates, and cannabis are associated with an increased likelihood of developing atrial fibrillation, a newly-published 11-year study shows.

Subscribe to Newsletter